S. Trabulus Et Al. , "Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever," CLINICAL TRANSPLANTATION , vol.32, no.8, 2018
Trabulus, S. Et Al. 2018. Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever. CLINICAL TRANSPLANTATION , vol.32, no.8 .
Trabulus, S., Korkmaz, M., Kaya, E., & Seyahi, N., (2018). Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever. CLINICAL TRANSPLANTATION , vol.32, no.8.
Trabulus, Sinan Et Al. "Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever," CLINICAL TRANSPLANTATION , vol.32, no.8, 2018
Trabulus, Sinan Et Al. "Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever." CLINICAL TRANSPLANTATION , vol.32, no.8, 2018
Trabulus, S. Et Al. (2018) . "Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever." CLINICAL TRANSPLANTATION , vol.32, no.8.
@article{article, author={Sinan TRABULUS Et Al. }, title={Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever}, journal={CLINICAL TRANSPLANTATION}, year=2018}